These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28414771)

  • 1. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of two stable oral suspensions for gabapentin.
    Nahata MC
    Pediatr Neurol; 1999 Mar; 20(3):195-7. PubMed ID: 10207927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
    Friciu M; Zaraa S; Roullin VG; Leclair G
    PLoS One; 2016; 11(10):e0164577. PubMed ID: 27727306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of gabapentin in SyrSpend SF.
    Sorenson B; Voudrie MA; Gehrig D
    Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes.
    St-Jean I; Friciu MM; Monfort A; MacMahon J; Forest JM; Walker S; Leclair G
    Can J Hosp Pharm; 2021; 74(4):327-333. PubMed ID: 34602620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization.
    Coache D; Friciu M; Bernine Marcellin R; Bonnemain L; Viau A; Roullin VG; Forest JM; Leclair G
    PLoS One; 2022; 17(6):e0270206. PubMed ID: 35749410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    McHenry AR; Wempe MF; Rice PJ
    Int J Pharm Compd; 2017; 21(3):251-254. PubMed ID: 28557788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of gabapentin 300-mg capsules repackaged in unit dose containers.
    Gupta A; Ciavarella AB; Rothman B; Faustino PJ; Khan MA
    Am J Health Syst Pharm; 2009 Aug; 66(15):1376-80. PubMed ID: 19635774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
    Walsh A; Ziegler B; Lingertat-Walsh K; Law S; Walker SE
    Int J Pharm Compd; 2021; 25(2):163-168. PubMed ID: 33798116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of Extemporaneously Prepared Acetazolamide Oral Suspensions at Two Temperatures.
    Gillium C; Friciu M; Abatzoglou N; Leclair G
    J Pediatr Pharmacol Ther; 2020; 25(8):723-729. PubMed ID: 33214784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
    Jarouche M; Ibrahim M; Pearson J; Low M; Rowe J
    Int J Pharm Compd; 2020; 24(1):77-82. PubMed ID: 32023219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
    Gorman G; Sokom S; Coward L; Arnold JJ
    Int J Pharm Compd; 2017; 21(2):164-170. PubMed ID: 28346213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF® in glass and plastic bottles and plastic syringes.
    Lingertat-Walsh K; Weilnau J; Cober MP; Ostrenga A; Poon B; Sales P; Law S; Dupuis LL; Walker SE
    J Oncol Pharm Pract; 2021 Jan; 27(1):78-87. PubMed ID: 32228132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.